Compare DexCom, Inc. (DXCM) vs Ishares Msci Brazil ETF (EWZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Ishares Msci Brazil ETF — how do they compare? DexCom, Inc. trades at $84.11 (market cap $31.86B), while Ishares Msci Brazil ETF trades at $43.54 (market cap $11.30B). The key difference: DexCom, Inc. is far larger — about 2.8× Ishares Msci Brazil ETF's market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, DexCom, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DexCom, Inc. for 62 Days and Ishares Msci Brazil ETF for 50 Days on average.
| DXCM | EWZ | |
|---|---|---|
Market Cap | $31.86B | $11.30B |
Volume | 3,607,070 | 44,036,597 |
Sector | Health | Broad Market / Factor |
52-Week High | $92.34 | $43.00 |
52-Week Low | $54.84 | $28.79 |
Typical Hold Time | 62 Days | 50 Days |
Enterprise Value | $31.32B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DexCom (DXCM) trades at $84.41, showing modest daily gains of 0.13%. The stock demonstrates strong fundamental performance with consistent earnings beats and robust revenue growth, reaching $4.66 billion in 2025. Technical indicators show a bearish short-term trend with key support at $82. The company maintains impressive profitability with 20.12% net margins and 38.49% ROE, supported by growing adoption of CGM technology in diabetes care.
DXCM presents a compelling growth story with expanding market opportunities in Type 2 diabetes care. Analyst consensus remains strongly bullish with 81% buy ratings and $95.07 price target, suggesting 13% upside. Key risks include reimbursement challenges and competitive pressures. The company's strong cash flow generation and institutional support provide solid foundation for continued growth.
EWZ, the iShares MSCI Brazil ETF, trades at $42.59, up 0.52% today, with a bullish technical signal from moving averages but overbought RSI readings. The ETF is heavily influenced by Brazil's upcoming October 2026 election, with institutional investors accumulating call options betting on a favorable outcome. Recent news highlights EWZ as a diversifier from U.S. tech exposure, though it faces competition from lower-fee alternatives like FLBR.
The outlook for EWZ hinges on Brazil's election result and commodity trends, offering asymmetric upside if pro-market policies prevail. Key risks include political volatility, U.S. tariff impacts, and currency fluctuations. Wall Street sentiment is cautiously optimistic, with unusual options activity signaling speculative interest in near-term gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Ishares Msci Brazil ETF
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →
